Abstract
Experimental studies indicated the clearance rate constant of11C-acetate as an index of regional myocardial oxygen consumption. To assess the response of the clearance rate from the left ventricular (LV) myocardium to the change in plasma substrate levels and to the increase in the cardiac work load in normal subjects, a total of 18 dynamic positron emission tomographic studies were performed at rest in the fasting state (control) (n=7), after oral glucose administration (n=4), and during dobutamine infusion (n=7) in 7 normal volunteers. The clearance rate constant (Kmono) was similar in the control (0.065±0.017 min< 1) and glucose loading states (0.059±0.OO8 min−1), whereas a significant increase in Kmono was observed during dobutamine infusion (0.106±0.018 min−1) (p< 0.01) in relation to the increase in the pressure-rate product with a correlation coefficient of 0.873 (p< 0.01). When the LV myocardium was divided into 6 segments, there were no significant differences among the segments in Kmono values in any condition. These normal responses should be valuable for assessing oxidative metabolic reserve and regional changes in oxidative metabolism in patients with coronary artery disease.
Similar content being viewed by others
References
Schelbert HR, Henze E, Phelps ME: Emission tomography of the heart.Semin Nucl Med 10: 355–373, 1980
Bergmann SR, Fox KAA, Geltman EM, et al: Positron emission tomography of the heart.Prog Cardiovasc Dis 28: 165–194, 1985
Schon HR, Schelbert HR, Robinson G, et al: C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. I. Kinetics of C-11 palmitic acid in normal myocardium.Am Heart J 103:532–547, 1982
Grover-McKay M, Schelbert HR, Schwaiger M, et al: Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis.Circulation 74: 281–292, 1986
Marshall RC, Tillisch JH, Phelps ME, et al: Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography,18F-labeled fluorodeoxyglucose and N-13 ammonia.Circulation 67: 766–788, 1983
Tillisch J, Brunken R, Marshall R, et al: Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.N Eng J Med 314: 884–888, 1986
Tamaki N, Yonekura Y, Yamashita K, et al: Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting.Am J Cardiol 64: 860–865, 1989
Schelbert H, Henze E, Sochor H, et al: Effect of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction.Am Heart J 111: 1055–1064, 1986
Berry JJ, Baker JA, Pieper KS, et al: The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.J Nucl Med 32: 1518–1525, 1991
Brown M, Marshall DR, Sobel BE, et al: Delineation of myocardial utilization with carbon-11-labeled acetate.Circulation 76: 687–696, 1987
Buxton DB, Schwaiger M, Nguyen A, et al: Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux.Circ Res 63: 628–634, 1988
Brown MA, Myears DW, Bergmann SR: Noninvaive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and dynamic positron emission tomography.JACC 12: 1054–1063, 1988
Buxton DB, Nienaber CA, Luxen A, et al: Noninvasive quantitation of regional myocardial oxygen consumptionin vivo with l-11C acetate and dynamic positron emission tomography.Circulation 79: 134–142, 1989
Brown MA, Myears DW, Bergmann SR: Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization.J Nucl Med 30: 187–193, 1989
Ambrecht JJ, Buxton DB, Brunken RC, et al: Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C] acetate and dynamic positron tomography.Circulation 80: 863–872, 1989
Henes CG, Bergmann SR, Walsh MN, et al: Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate.J Nucl Med 30: 1489–1499, 1989
Walsh MN, Geltman EM, Brown MA, et al: Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography using carbon-11 acetate in patients with myocardial infarction.J Nucl Med 30: 1798–1808, 1989
Gropler RJ, Siegel BA, Geltman EM: Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow.J Nucl Med 32: 245–251, 1991
Pike VW, Eakins MN, Allan RM et al: Preparation of [111C]acetate as agent for the study of myocardial metabolism by positron emission tomography.Int J Appl Radiat Isot 33: 505–512, 1982
Stratmann HG, Kennedy H: Evaluation of coronary artery disease in the patients unable to exercise: alternatives to exercise stress testing.Am Heart J 117: 1344–1365, 1989
Tamaki N, Kawamoto M, Takahashi N, et al: Metabolic reserve in normal myocardium assessed by positron emission tomography with C-11 palmitate.Ann Nucl Med 5: 53–58, 1991
Senda M, Tamaki N, Yonekura Y, et al: Performance characteristics of Positologica III, a whole body positron emission tomograph.J Comput Assist Tomogr 9: 940–946, 1985
Randle PJ, England PJ, Denton RM: Control of the tricarboxylate cycle and its interaction with glycolysis during aceta e ut lization in rat heart.Biochem J 117: 677–695, 1970
Nelson RR, Gobel FL, Jorgensen CR, et al: Hemodynami cprediction of myocardial oxygen consumption during static and dynamic exerciseCirculation 50: 1179–1189, 1974
Rooke GA, Feigl EO: Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting.Circ Res 50: 273–286, 1982
Neely JR, Rovetto MJ, Oran JF: Myocardial utilization of carbohydrate and lipids.Prog Cardiovasc Dis 15: 89–301, 1972
Tamaki N, Yonekura Y, Kawamoto M, et al: Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.J Nucl Med 32: 2152–2157, 1991
Hicks RJ, Herman WH, Kalff et al: Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography.JACC 18: 101–111, 1991
Tuttle RR, Millis J: Dobutamine. Development of new catecholamine to selectively increase cardiac contractility.Circ Res 36: 185–196, 1975
Meyer SL, Curry GC, Donsky MS, et al: Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.Am J Cardiol 8: 103–108, 1976
Mason JR, Palac RT, Freeman ML, et al: Thallium-201 scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease.Am Heart J 107: 481–485, 1984
Berthe C, Pierard LA, Hiernaux M, et al: Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dubutamine infusion.Am J Cardiol 58: 1167–1172, 1986
Wolpers HG, Nguyen N, Buck A, et al: Relationship of C-ll acetate kinetics and hemodynamic performance in the canine heart (abstr).J Nucl Med 31: 785, 1990
Buck A, Wolpers HG, Hutchins GD, et al: Effects of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET.J Nucl Med 32: 1950–1957, 1991
Author information
Authors and Affiliations
Additional information
This work was supported in part by a grant-in aid from the Ministry of Education, Science and Culture, Tokyo, Japan.
Rights and permissions
About this article
Cite this article
Tamaki, N., Magata, Y., Takahashi, N. et al. Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states. Ann Nucl Med 6, 221–228 (1992). https://doi.org/10.1007/BF03164658
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164658